US Stock Reports, Quotes and News
Cadence Design Systems, Inc. (NASDAQ:CDNS) reported a robust first quarter in 2024, surpassing its own financial guidance with a total revenue of $1.009 billion. The company's strong performance is backed by significant design activity in key technology areas and a record backlog that positions it well for the future.
According to Counterpoint Research, Apple’s (AAPL) iPhone sales in China plummeted by 19% during the March quarter, marking the device's poorest performance in the region since the onset of Covid around 2020.
Novartis (SIX:NOVN) (NVSEF) shares surged 4.7% in European trading Tuesday after the Swiss pharmaceutical company's release of impressive first-quarter results.
Strategists at Goldman Sachs have recently pointed to two potential shifts in the risk landscape: the broadening of global growth and a reduction in inflation fears.
On Tuesday, Renault reported a 1.8% increase in first-quarter revenue, driven by higher sales from its financing arm due to rising interest rates, and a 2.6% increase in car sales volumes compared to the previous year.
Investing.com– U.S. stock index futures rose in evening deals on Sunday, as Wall Street attempted a recovery after clocking two straight weeks of steep losses on a technology rout and waning expectations of interest rate cuts.
Investing.com– Salesforce Inc (NYSE:CRM) has failed to reach an agreement to take over data-management software firm Informatica Inc (NYSE:INFA) after the two could not agree to a price, reports from the Wall Street Journal and Reuters showed on Sunday.
Investing.com– Shares of Australian mineral sands miner Base Resources Ltd (ASX:BSE) more than doubled in value on Monday after it entered a deal to be bought by North American peer Energy Fuels (TSX:EFR) Inc (NYSE:UUUU) for an equity value of A$375 million ($241.7 million)
Investing.com– Most Asian stocks rose on Monday, rebounding from steep losses in the prior week amid growing bets that a conflict between Iran and Israel will not worsen, although sentiment still remained on edge.
As the Q4 FY24 earnings season is going on, Goldman Sachs (NYSE:GS) analysts have recalibrated their projections for the Indian pharmaceutical sector, factoring in a spectrum of variables from monthly sales data to currency fluctuations. Notably, the sector continues to trade at valuations exceeding one standard deviation above its five-year average, largely propelled by the resilience of major players like Sun Pharma (NS:SUN), Cipla (NS:CIPL), and Divi’s Laboratories.
Investing.com– Elon Musk had pushed for a 20% headcount reduction in Tesla Inc (NASDAQ:TSLA), Bloomberg reported on Sunday, citing a source close to the EV maker’s CEO as it undertakes a pivot into autonomous vehicles following a drop in deliveries.
Investing.com – Japan stocks were higher after the close on Monday, as gains in the Mining, Chemical, Petroleum & Plastic and Warehousing sectors led shares higher.